ORCHARD END DIAGNOSTICS LTD

Executive Summary

Orchard End Diagnostics Ltd is a newly established micro-entity with sound liquidity and current compliance status. While limited operational history and concentrated ownership warrant further scrutiny, the company shows no immediate solvency or regulatory concerns. Further due diligence should focus on operational performance and governance practices.

ORCHARD END DIAGNOSTICS LTD - Analysis Report

Company Number: 15055629

Analysis Date: 2025-07-20 15:29 UTC

1. Risk Rating: LOW
   The company is a recently incorporated micro-entity with a positive net asset position and no overdue filings. Its financial data shows net current assets well in excess of current liabilities, indicating an ability to meet short-term obligations.

2. Key Concerns:

• Limited operational history: Incorporated in August 2023, the company has less than one full year of financial data, which limits trend analysis and assessment of business sustainability.
• Minimal scale: With only one employee and micro-entity status, the company may face challenges in scaling operations or generating significant revenues.
• Concentrated control: One individual holds 75-100% ownership and voting rights, which could present governance risks if not managed transparently.

3. Positive Indicators:

• Strong liquidity position: Current assets (£15,337) exceed current liabilities (£2,914) by a comfortable margin, suggesting no immediate cash flow issues.
• Compliance track record: Both accounts and confirmation statement filings are up to date, indicating sound regulatory adherence.
• Professional management: Directors are medical professionals consistent with the company’s specialist medical practice SIC code, supporting operational relevance.

4. Due Diligence Notes:

• Review business plan and revenue generation since incorporation to assess operational viability and growth prospects.
• Examine cash flow trends and sources of capital to verify sustainability beyond initial funding.
• Confirm absence of any director disqualifications or regulatory issues beyond Companies House records.
• Investigate related party transactions given the high ownership concentration.